March 2018

Volume 26 Issue 3

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
One of our colleagues, Andrew Michaels, MD, Director of the Cardiac Catheterization Laboratory at St. Joseph Hospital in Eureka, California, recently asked about the consent process for cardiac cath cases. 
Our procedure days are expanding, because we typically can’t get all the cases done in just one day a week. We meet in the ICU the morning after, or on the floor, at either 7 or 7:30 am, with the entire team. Rounding more as a team, going over the c…
Placement of covered stents in the aneurysmal segment is evolving as a less-invasive percutaneous option of excluding the aneurysm, rather than surgical ligation. Covered stents, when placed optimally, effectively seal off flow to the aneurysmal sac.…
In this month’s article, we have asked Anne Beekman, MedAxiom Consulting, and Keely Macmillan, Archway Health, to discuss what the new voluntary bundles offer as an opportunity for cath lab programs considering percutaneous coronary intervention (PCI…
The Tryton side branch stent is a specially designed stand-alone device that has been shown to effectively stent bifurcation lesions. The CorPath GRX robotic heart catheterization system was developed for reducing radiation exposure to the interventi…
If patients are not already on dual antiplatelet therapy when they come in, achieving that status is going to take time and there is going to be a window in which they are not protected. One of the advantages of the short-term infusion of tirofiban i…
While percutaneous transluminal angioplasty (PTA) enjoys high procedural success rates in focal lesions, the first line of therapy for the elderly, diabetic, end-stage renal disease (ESRD) patient population tends to be amputation.(8)
Featuring an expert operator discussion with Dr. Amir Kaki, Medical Director of the Cardiac Cath Lab, Detroit Medical Center Heart Hospital, Associate Professor of Medicine, Wayne State School of Medicine, and the Director of the CHIP Fellowship.
Physicians strive to avoid unnecessary invasive angiograms when determining the extent of coronary artery disease (CAD) in a patient as well as CAD’s impact on blood flow to the heart.
When possible, percutaneous transluminal angioplasty (PTA) should be considered as a first-line choice for diabetic patients with foot ulcers and peripheral arterial disease with obstruction, as opposed to amputation.